A deeper understanding of the mechanisms related to IGF-BP2 in particular could pave the way to establish TAVRs earlier, if necessary, especially in the male gender, to treat the combination of these cardiovascular diseases even more effectively and successfully. This evidence concerns the gene IGFBP2 and cardiovascular disorder.